People

Guy Harmelin is published by MGX as Chief Investment Officer, Advanced Technology; Investment Committee Member. Physician and technology investor, previously an adviser to G42 and CIM Group and an investment executive at 7-main and Harel. Co-founded computational drug-discovery company RondinX and Ayala Pharma; holds an MD from the University of Florence.